ES521370A0 - A PROCEDURE FOR OBTAINING A POLYDOMA. - Google Patents
A PROCEDURE FOR OBTAINING A POLYDOMA.Info
- Publication number
- ES521370A0 ES521370A0 ES521370A ES521370A ES521370A0 ES 521370 A0 ES521370 A0 ES 521370A0 ES 521370 A ES521370 A ES 521370A ES 521370 A ES521370 A ES 521370A ES 521370 A0 ES521370 A0 ES 521370A0
- Authority
- ES
- Spain
- Prior art keywords
- polydoma
- procedure
- obtaining
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/46—Hybrid immunoglobulins
- C07K16/468—Immunoglobulins having two or more different antigen binding sites, e.g. multifunctional antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
- A61K51/1084—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody the antibody being a hybrid immunoglobulin
- A61K51/109—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody the antibody being a hybrid immunoglobulin immunoglobulins having two or more different antigen-binding sites or multifunctional antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2123/00—Preparations for testing in vivo
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Epidemiology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US36778482A | 1982-04-12 | 1982-04-12 |
Publications (2)
Publication Number | Publication Date |
---|---|
ES521370A0 true ES521370A0 (en) | 1985-04-16 |
ES8504461A1 ES8504461A1 (en) | 1985-04-16 |
Family
ID=23448582
Family Applications (7)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES521370A Expired ES8504461A1 (en) | 1982-04-12 | 1983-04-11 | Antibodies having dual specificities, their preparation and uses therefor. |
ES527963A Granted ES527963A0 (en) | 1982-04-12 | 1983-12-12 | AN IMMUNO ASSAY PROCEDURE |
ES533931A Expired ES8506091A1 (en) | 1982-04-12 | 1984-07-02 | Antibodies having dual specificities, their preparation and uses therefor. |
ES533930A Expired ES8603080A1 (en) | 1982-04-12 | 1984-07-02 | Antibodies having dual specificities, their preparation and uses therefor. |
ES537257A Expired ES8606655A1 (en) | 1982-04-12 | 1984-10-31 | Antibodies having dual specificities, their preparation and uses therefor. |
ES538727A Expired ES8604424A1 (en) | 1982-04-12 | 1984-12-18 | Antibodies having dual specificities, their preparation and uses therefor. |
ES545247A Expired ES8607386A1 (en) | 1982-04-12 | 1985-07-16 | Antibodies having dual specificities, their preparation and uses therefor. |
Family Applications After (6)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES527963A Granted ES527963A0 (en) | 1982-04-12 | 1983-12-12 | AN IMMUNO ASSAY PROCEDURE |
ES533931A Expired ES8506091A1 (en) | 1982-04-12 | 1984-07-02 | Antibodies having dual specificities, their preparation and uses therefor. |
ES533930A Expired ES8603080A1 (en) | 1982-04-12 | 1984-07-02 | Antibodies having dual specificities, their preparation and uses therefor. |
ES537257A Expired ES8606655A1 (en) | 1982-04-12 | 1984-10-31 | Antibodies having dual specificities, their preparation and uses therefor. |
ES538727A Expired ES8604424A1 (en) | 1982-04-12 | 1984-12-18 | Antibodies having dual specificities, their preparation and uses therefor. |
ES545247A Expired ES8607386A1 (en) | 1982-04-12 | 1985-07-16 | Antibodies having dual specificities, their preparation and uses therefor. |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP0105360A4 (en) |
JP (2) | JPH0753119B2 (en) |
AT (1) | AT394577B (en) |
AU (1) | AU550486B2 (en) |
CA (1) | CA1213229A (en) |
CH (1) | CH672796A5 (en) |
ES (7) | ES8504461A1 (en) |
FI (1) | FI834529A0 (en) |
GB (4) | GB2128631B (en) |
IT (1) | IT1219778B (en) |
WO (1) | WO1983003679A1 (en) |
Families Citing this family (59)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3177776B2 (en) * | 1988-09-27 | 2001-06-18 | 武田薬品工業株式会社 | Hybrid monoclonal antibodies, antibody-producing polydomas and antibody-containing drugs |
US5292668A (en) * | 1981-12-21 | 1994-03-08 | Boston Biomedical Research Institute, Inc. | Bispecific antibody determinants |
CA1214123A (en) * | 1983-01-20 | 1986-11-18 | Masashi Matsui | Cell lines for use in the preparation of hybridoma cells |
GB2148299B (en) * | 1983-09-01 | 1988-01-06 | Hybritech Inc | Antibody compositions of therapeutic agents having an extended serum half-life |
EP0467416A1 (en) * | 1983-09-01 | 1992-01-22 | Hybritech Incorporated | Antibody compositions of therapeutic agents having an extended serum half-life |
JPH0617909B2 (en) * | 1984-04-23 | 1994-03-09 | ボストン バイオメディカル リサーチ インスティテュート,インコーポレイテッド | Bispecific antibody determinant |
NL8501219A (en) * | 1985-04-29 | 1986-11-17 | Stichting Vrienden Van De Stic | IMMUNOLOGICAL COMPLEX, ITS PREPARATION AND APPLICATION. |
US5453269A (en) * | 1986-04-14 | 1995-09-26 | The General Hospital Corporation | Heterobifunctional antibodies having dual specificity for fibrin and thrombolylic agents and methods of use |
JP2635343B2 (en) | 1986-04-14 | 1997-07-30 | ザ・ジェネラル・ホスピタル・コーポレーション | Heterobifunctional antibodies and methods of use |
FR2604092B1 (en) * | 1986-09-19 | 1990-04-13 | Immunotech Sa | IMMUNOREACTIVES FOR TARGETING ANIMAL CELLS FOR VISUALIZATION OR DESTRUCTION IN VIVO |
GB8626412D0 (en) * | 1986-11-05 | 1986-12-03 | Clark M R | Antibodies |
GB8626413D0 (en) * | 1986-11-05 | 1986-12-03 | Gilliland L K | Antibodies |
US5053226A (en) * | 1987-07-15 | 1991-10-01 | Board Of Regents, The University Of Texas System | Monoclonal antibodies binding platinum complexes |
EP0308936B1 (en) * | 1987-09-23 | 1994-07-06 | Bristol-Myers Squibb Company | Antibody heteroconjugates for the killing of HIV-infected cells |
GB2218100A (en) * | 1988-03-02 | 1989-11-08 | Erling Sundrehagen | Conjugates for the detection and/or quantification of antigenic substances in body fluids |
US4892824A (en) * | 1988-03-15 | 1990-01-09 | Synbiotics Corporation | Fast track method for producing monoclonal bi-specific immunoglobulins |
US5372812A (en) * | 1988-04-04 | 1994-12-13 | The General Hospital Corporation | Composition and method for acceleration of clot lysis |
US5582862A (en) * | 1988-04-04 | 1996-12-10 | General Hospital Corporation | Antibodies that bind to α2-antiplasmin crosslinked to fibrin which do not inhibit plasma α2-antiplasmin |
JPH02196799A (en) * | 1988-04-08 | 1990-08-03 | Agency Of Ind Science & Technol | Complex of anti-human cancer protein |
US5851527A (en) * | 1988-04-18 | 1998-12-22 | Immunomedics, Inc. | Method for antibody targeting of therapeutic agents |
IT1235349B (en) * | 1988-12-23 | 1992-06-30 | Biodata Spa | IMMUNOLOGICAL TEST FOR HOMOGENEOUS DETERMINATIONS |
US5217713A (en) * | 1988-12-27 | 1993-06-08 | Takeda Chemical Industries, Ltd. | Cytotoxic bispecific monoclonal antibody, its production and use |
CA2006408A1 (en) * | 1988-12-27 | 1990-06-27 | Susumu Iwasa | Bispecific monoclonal antibody, its production and use |
WO1990012109A1 (en) * | 1989-03-30 | 1990-10-18 | Board Of Regents, The University Of Texas System | Monoclonal antibodies binding platinum complexes |
FR2652004B1 (en) * | 1989-09-21 | 1994-10-28 | Immunotech Partners | NOVEL HYDROPHILIC DERIVATIVES, APPLICATION TO DIAGNOSIS AND THERAPEUTICS, DIAGNOSTIC OR THERAPEUTIC KITS AND IMMUNOLOGICAL REAGENTS. |
EP0515571B1 (en) * | 1990-02-16 | 1998-12-02 | Boston Biomedical Research Institute | Hybrid reagents capable of selectively releasing molecules into cells |
TW212184B (en) * | 1990-04-02 | 1993-09-01 | Takeda Pharm Industry Co Ltd | |
EP0511011B1 (en) * | 1991-04-26 | 1996-10-23 | Surface Active Limited | Novel antibodies and methods for their use |
GB9316369D0 (en) * | 1993-08-06 | 1993-09-22 | Surface Active Ltd | Diagnostic method |
US5541110A (en) | 1994-05-17 | 1996-07-30 | Bristol-Myers Squibb | Cloning and expression of a gene encoding bryodin 1 from Bryonia dioica |
GB9421468D0 (en) * | 1994-10-18 | 1994-12-07 | Surface Active Ltd | Biosensor |
CA2266339A1 (en) * | 1996-09-20 | 1998-03-26 | The General Hospital Corporation | Chimeric, humanized and single chain antibodies to alpha-2-antiplasmin |
US20020132274A1 (en) | 2001-01-17 | 2002-09-19 | Nevalainen Marja T. | Diagnostic and monitorings methods for cancer |
EP1545613B9 (en) | 2002-07-31 | 2012-01-25 | Seattle Genetics, Inc. | Auristatin conjugates and their use for treating cancer, an autoimmune disease or an infectious disease |
CN107213469A (en) | 2003-11-06 | 2017-09-29 | 西雅图基因公司 | Monomethyl valine compound that can be with ligand coupling |
EP1740530B8 (en) | 2004-03-16 | 2017-03-01 | Temple University - Of The Commonwealth System of Higher Education | Substituted phenoxy- and phenylthio-derivatives for treating proliferative disorders |
JP2008519863A (en) | 2004-11-12 | 2008-06-12 | シアトル ジェネティクス インコーポレイティッド | Auristatin having an aminobenzoic acid unit at the N-terminus |
EP2511299A1 (en) | 2005-04-19 | 2012-10-17 | Seattle Genetics, Inc. | Humanized anti-CD70 binding agents and uses thereof |
WO2007011968A2 (en) | 2005-07-18 | 2007-01-25 | Seattle Genetics, Inc. | Beta-glucuronide-linker drug conjugates |
WO2008070593A2 (en) | 2006-12-01 | 2008-06-12 | Seattle Genetics, Inc. | Variant target binding agents and uses thereof |
EP2120915B1 (en) | 2007-01-22 | 2011-09-28 | Genentech, Inc. | Polyelectrolyte precipitation and purification of antibodies |
CA2723197C (en) | 2008-05-02 | 2017-09-19 | Seattle Genetics, Inc. | Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylation |
WO2011133658A1 (en) | 2010-04-22 | 2011-10-27 | Boston Medical Center Corporation | Compositions and methods for targeting and delivering therapeutics into cells |
US9353150B2 (en) | 2012-12-04 | 2016-05-31 | Massachusetts Institute Of Technology | Substituted pyrazino[1′,2′:1 ,5]pyrrolo[2,3-b]-indole-1,4-diones for cancer treatment |
KR102178606B1 (en) | 2013-03-15 | 2020-11-13 | 자임워크스 인코포레이티드 | Cytotoxic and anti-mitotic compounds, and methods of using the same |
WO2015053381A1 (en) * | 2013-10-10 | 2015-04-16 | 幸成 加藤 | Anti-podoplanin antibody |
KR102384740B1 (en) | 2013-12-27 | 2022-04-07 | 자임워크스 인코포레이티드 | Sulfonamide-containing linkage systems for drug conjugates |
CN113416229A (en) | 2014-09-17 | 2021-09-21 | 酵活有限公司 | Cytotoxic and antimitotic compounds, and methods of use thereof |
TWI618697B (en) | 2015-11-03 | 2018-03-21 | 財團法人工業技術研究院 | Compounds, linker-drugs and ligand-drug conjugates |
CA3017527A1 (en) | 2016-03-25 | 2017-09-28 | Seattle Genetics, Inc. | Process for the preparation of pegylated drug-linkers and intermediates thereof |
WO2017197045A1 (en) | 2016-05-11 | 2017-11-16 | Movassaghi Mohammad | Convergent and enantioselective total synthesis of communesin analogs |
JP2020512312A (en) | 2017-03-24 | 2020-04-23 | シアトル ジェネティックス, インコーポレイテッド | Process for the preparation of glucuronide drug-linker and its intermediates |
US11932650B2 (en) | 2017-05-11 | 2024-03-19 | Massachusetts Institute Of Technology | Potent agelastatin derivatives as modulators for cancer invasion and metastasis |
US10640508B2 (en) | 2017-10-13 | 2020-05-05 | Massachusetts Institute Of Technology | Diazene directed modular synthesis of compounds with quaternary carbon centers |
CA3110096A1 (en) * | 2018-08-30 | 2020-03-05 | Innovative Cellular Therapeutics CO., LTD. | Chimeric antigen receptor cells for treating solid tumor |
JP2022532192A (en) | 2019-05-10 | 2022-07-13 | 武田薬品工業株式会社 | Antibody drug conjugate |
TW202138388A (en) | 2019-12-30 | 2021-10-16 | 美商西根公司 | Methods of treating cancer with nonfucosylated anti-cd70 antibodies |
PE20231947A1 (en) | 2020-11-09 | 2023-12-05 | Takeda Pharmaceuticals Co | ANTIBODY AND DRUG CONJUGATES |
AU2022304582A1 (en) | 2021-06-29 | 2024-02-01 | Seagen Inc. | Methods of treating cancer with a combination of a nonfucosylated anti-cd70 antibody and a cd47 antagonist |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4130634A (en) * | 1974-03-15 | 1978-12-19 | University Of Illinois Foundation | Method for detecting and quantifying antigens |
US4331647A (en) * | 1980-03-03 | 1982-05-25 | Goldenberg Milton David | Tumor localization and therapy with labeled antibody fragments specific to tumor-associated markers |
US4376110A (en) * | 1980-08-04 | 1983-03-08 | Hybritech, Incorporated | Immunometric assays using monoclonal antibodies |
US4474893A (en) * | 1981-07-01 | 1984-10-02 | The University of Texas System Cancer Center | Recombinant monoclonal antibodies |
-
1983
- 1983-04-11 ES ES521370A patent/ES8504461A1/en not_active Expired
- 1983-04-11 CA CA000425558A patent/CA1213229A/en not_active Expired
- 1983-04-12 EP EP19830901672 patent/EP0105360A4/en not_active Ceased
- 1983-04-12 IT IT20548/83A patent/IT1219778B/en active
- 1983-04-12 CH CH6700/83A patent/CH672796A5/de not_active IP Right Cessation
- 1983-04-12 AU AU15559/83A patent/AU550486B2/en not_active Expired
- 1983-04-12 GB GB08332646A patent/GB2128631B/en not_active Expired
- 1983-04-12 WO PCT/US1983/000525 patent/WO1983003679A1/en not_active Application Discontinuation
- 1983-04-12 AT AT0901883A patent/AT394577B/en not_active IP Right Cessation
- 1983-12-09 FI FI834529A patent/FI834529A0/en not_active Application Discontinuation
- 1983-12-12 ES ES527963A patent/ES527963A0/en active Granted
-
1984
- 1984-07-02 ES ES533931A patent/ES8506091A1/en not_active Expired
- 1984-07-02 ES ES533930A patent/ES8603080A1/en not_active Expired
- 1984-10-31 ES ES537257A patent/ES8606655A1/en not_active Expired
- 1984-12-18 ES ES538727A patent/ES8604424A1/en not_active Expired
-
1985
- 1985-07-16 ES ES545247A patent/ES8607386A1/en not_active Expired
- 1985-12-09 GB GB08530309A patent/GB2169921B/en not_active Expired
- 1985-12-09 GB GB08530308A patent/GB2168998B/en not_active Expired
- 1985-12-09 GB GB08530310A patent/GB2167086B/en not_active Expired
-
1987
- 1987-01-05 JP JP62000342A patent/JPH0753119B2/en not_active Expired - Lifetime
-
1994
- 1994-02-10 JP JP6016728A patent/JP2562002B2/en not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES521370A0 (en) | A PROCEDURE FOR OBTAINING A POLYDOMA. | |
ES519925A0 (en) | A PROCEDURE FOR FORMING AN ABSORBENT MATERIAL. | |
ES534202A0 (en) | A PROCEDURE FOR PREPARING NEW CEFEM COMPOUNDS. | |
ES537668A0 (en) | A PROCEDURE FOR PREPARING N-FORMIL-3-PHENOXI-1-AZETIDINCARBOXAMIDES | |
ES523195A0 (en) | A PROCEDURE FOR PREPARING ALKYL-GLYCOSIDES | |
ES523064A0 (en) | PROCEDURE FOR PREPARING AZETIDINS. | |
ES519652A0 (en) | A PROCEDURE FOR OBTAINING S-ADENOSIL-METIONINE. | |
AR231308A1 (en) | A PROCEDURE FOR PREPARING 1-BE-D-RIBOFURANOSIL-1,2,4-TRIAZOLCARBOXAMIDE RIVAVIRINE | |
ES520364A0 (en) | A PROCEDURE FOR PREPARING CEFEM COMPOUNDS. | |
ES523193A0 (en) | A PROCEDURE FOR PREPARING 3-PHENOXI-1-AZETIDINCARBO-XZNMIDAS | |
FI73942B (en) | A UTLOESARE MANOEVRERBAR FOERDELNINGSVENTIL FOER EN UNDER TRYCK STAOENDE BEHAOLLARE. | |
ES518758A0 (en) | A PROCEDURE FOR PREPARING AZETIDINS. | |
ES538192A0 (en) | A PROCEDURE FOR PREPARING A 2-JOKE-6B-9A - DIFLUORO-11B, 17A, 21-TRIHIDROXI-1, 4-PREGNADIEN-3, 20-DIONA-17, 21-DIESTER | |
ES521813A0 (en) | PROCEDURE FOR PREPARING ALCOHYL-POLYSACCHARIDES. | |
ES520531A0 (en) | PROCEDURE FOR PREPARING TIOETERES. | |
ES524772A0 (en) | A PROCEDURE FOR PREPARING PHENYLANILINS-N. SUBSTITUTED. | |
ES522716A0 (en) | A PROCEDURE FOR PREPARING A PIRAZOLE DERIVATIVE. | |
ES519936A0 (en) | A PROCEDURE FOR PREPARING PIRIMIDONE DERIVATIVES. | |
ES523277A0 (en) | A PROCEDURE FOR PREPARING PEPTIDES. | |
ES527278A0 (en) | A PROCEDURE FOR OBTAINING 2,5-ANHYDRO-3,4,6-TRI-O-ACIL-D-ALONSELENOCARBOXAMIDE | |
ES527108A0 (en) | A PROCEDURE FOR PREPARING 2-ALCOXY-5- (PIRIDINIL) PIRIDINAS | |
NO157221C (en) | ELECTROPLETING PROCEDURE. | |
ES520370A0 (en) | A PROCEDURE FOR OBTAINING ISOXAZOLOPYRIMIDINE DERIVATIVES. | |
ES520879A0 (en) | A PROCEDURE FOR PREPARING 1-HYDROXYETHYL-1H-TETRAZOLE-5-THYOL OPTIONALLY PROTECTED. | |
ES527247A0 (en) | A PROCEDURE FOR OBTAINING CEMENT-CONCRETE |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD1A | Patent lapsed |
Effective date: 19970401 |